Douglas A Levine MD
Douglas A Levine MD
NYU Langone Health
Verified email at nyumc.org
Title
Cited by
Cited by
Year
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
50462011
Integrated genomic characterization of endometrial carcinoma
DA Levine
Nature 497 (7447), 67-73, 2013
23492013
Inferring tumour purity and stromal and immune cell admixture from expression data
K Yoshihara, M Shahmoradgoli, E Martínez, R Vegesna, H Kim, ...
Nature communications 4 (1), 1-11, 2013
18642013
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
14742018
Absolute quantification of somatic DNA alterations in human cancer
SL Carter, K Cibulskis, E Helman, A McKenna, H Shen, T Zack, PW Laird, ...
Nature biotechnology 30 (5), 413-421, 2012
13932012
Rethinking ovarian cancer: recommendations for improving outcomes
S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ...
Nature Reviews Cancer 11 (10), 719-725, 2011
12152011
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
10972018
Evaluating cell lines as tumour models by comparison of genomic profiles
S Domcke, R Sinha, DA Levine, C Sander, N Schultz
Nature communications 4 (1), 1-10, 2013
10442013
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
9982018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
8942018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
8802018
Resistance to therapy caused by intragenic deletion in BRCA2
SL Edwards, R Brough, CJ Lord, R Natrajan, R Vatcheva, DA Levine, ...
Nature 451 (7182), 1111-1115, 2008
8792008
OncoKB: a precision oncology knowledge base
D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ...
JCO precision oncology 1, 1-16, 2017
8232017
Integrated genomic characterization of endometrial carcinoma
G Getz, SB Gabriel, K Cibulskis, E Lander, A Sivachenko, C Sougnez, ...
Nature Publishing Group, 2013
7982013
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast, V Beral, JS Berek, ...
Nature reviews Cancer 15 (11), 668-679, 2015
7112015
Network modeling links breast cancer susceptibility and centrosome dysfunction
MA Pujana, JDJ Han, LM Starita, KN Stevens, M Tewari, JS Ahn, ...
Nature genetics 39 (11), 1338-1349, 2007
6732007
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
DS Chi, EL Eisenhauer, J Lang, J Huh, L Haddad, NR Abu-Rustum, ...
Gynecologic oncology 103 (2), 559-564, 2006
6212006
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
5592016
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
5492013
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer
KL Bolton, G Chenevix-Trench, C Goh, S Sadetzki, SJ Ramus, BY Karlan, ...
Jama 307 (4), 382-389, 2012
5402012
The system can't perform the operation now. Try again later.
Articles 1–20